Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

Published:2016-04-28 Issue:17 Volume:127 Page:2122-2130
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Nadeu Ferran¹^ORCID,Delgado Julio¹²,Royo Cristina¹,Baumann Tycho²,Stankovic Tatjana³,Pinyol Magda⁴,Jares Pedro¹²,Navarro Alba¹,Martín-García David¹,Beà Sílvia¹,Salaverria Itziar¹,Oldreive Ceri³,Aymerich Marta¹²,Suárez-Cisneros Helena⁴,Rozman Maria¹²,Villamor Neus¹²,Colomer Dolors¹²,López-Guillermo Armando¹²,González Marcos⁵,Alcoceba Miguel⁵,Terol Maria José⁶,Colado Enrique⁷,Puente Xose S.⁸,López-Otín Carlos⁸,Enjuanes Anna⁴,Campo Elías¹²⁹^ORCID

Affiliation:

1. Lymphoid Neoplasm Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain;

2. Hematology Department, Hospital Clínic, Barcelona, Spain;

3. School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;

4. Unitat de Genòmica, IDIBAPS, Barcelona, Spain;

5. Biología Molecular e Histocompatibilidad, Hospital Universitario, Salamanca, Spain;

6. Unidad de Hematología, Hospital Clínico Universitario, Valencia, Spain;

7. Servicio de Hematología y Hemoterapia, Hospital Universitario Central de Asturias, Oviedo, Spain;

8. Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; and

9. Departament d'Anatomia Patològica, Universitat de Barcelona, Barcelona, Spain

Abstract

Key Points Clonal and subclonal mutations of NOTCH1 and TP53, clonal mutations of SF3B1, and ATM mutations in CLL have an impact on clinical outcome. Clonal evolution in longitudinal samples occurs before and after treatment and may have an unfavorable impact on overall survival.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/17/2122/1393231/2122.pdf

Reference50 articles.

1. From pathogenesis to treatment of chronic lymphocytic leukaemia.;Zenz;Nat Rev Cancer,2010

2. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.;Hallek;Am J Hematol,2013

3. Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia.;Guièze;Blood,2015

4. Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.;Sutton;Haematologica,2015

5. Next-generation sequencing in chronic lymphocytic leukemia.;Villamor;Semin Hematol,2013

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): unraveling the biological gray zone of CLL/SLL in the era of novel therapies;Virchows Archiv;2024-09-07

2. Circular RNA as a Biomarker for Diagnosis, Prognosis and Therapeutic Target in Acute and Chronic Lymphoid Leukemia;Cell Biochemistry and Biophysics;2024-08-13

3. Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT);Leukemia Research;2024-08

4. Molecular Profiling of Small Mature B Cell Lymphomas; New Insights on Diagnosis and Treatment;Advances in Molecular Pathology;2024-08

5. CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: From interconnected signalling pathways to therapeutic strategies;Biochimie;2024-07